Bay Street News, May, 2024

SHANGHAI, China, May 22, 2024 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS”, “GDSH” or the “Company”) (NASDAQ: GDS; […]

BOCA RATON, Fla., May 22, 2024 (GLOBE NEWSWIRE) —  Entero Therapeutics, Inc. (formerly First Wave BioPharma, Inc.) (Nasdaq: ENTO) (“Entero” […]

1Q24 Revenue of $68.6 million at the high end of the guidance range. 1Q24 Non-GAAP Operating Income of $4.4 million […]

Charlotte, N.C., May 22, 2024 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device […]

GAITHERSBURG, Md., May 22, 2024 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering […]

TORONTO and HOUSTON, May 22, 2024 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage […]

TORONTO, May 22, 2024 (GLOBE NEWSWIRE) — Wesdome Gold Mines Ltd. (TSX:WDO, OTCQX:WDOFF) (“Wesdome” or the “Company”) today announces the […]

ROAD TOWN, British Virgin Islands, May 22, 2024 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) […]

BOUCHERVILLE, Quebec, May 22, 2024 (GLOBE NEWSWIRE) — LSL PHARMA GROUP INC. (TSXV: LSL) (the “Corporation” or “LSL Pharma “), […]

WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from […]